Affordable Access

deepdyve-link
Publisher Website

Pharmacodynamics of tepoxalin, sodium-salicylate and ketoprofen in an intravenous lipopolysaccharide inflammation model in broiler chickens.

Authors
  • de Boever, S
  • Neirinckx, E A
  • Meyer, E
  • de Baere, S
  • Beyaert, R
  • de Backer, P
  • Croubels, S
Type
Published Article
Journal
Journal of veterinary pharmacology and therapeutics
Publication Date
Dec 01, 2010
Volume
33
Issue
6
Pages
564–572
Identifiers
DOI: 10.1111/j.1365-2885.2010.01184.x
PMID: 21062309
Source
Medline
License
Unknown

Abstract

The pharmacodynamic properties of tepoxalin, Na-salicylate and ketoprofen were determined in an intravenous lipopolysaccharide (LPS) inflammation model in broiler chickens. The drugs were administered orally at a dose of 30, 50 and 3 mg/kg, respectively. LPS administration induces an increase in the intracellular expression of interleukin (IL)-1β and IL-6 and the secreted IL-6 plasma concentration. Furthermore, an elevation in body temperature is noted. Despite pretreatment with a single dose of the drugs and LPS administration on the T(max) of the drug after a second dose, no decrease was seen in systemic IL-6 levels. The intracellular expression of IL-1β in the heterophils was slightly decreased if LPS was administered in combination with each of the three drugs. Tepoxalin and Na-salicylate administration had no significant effect on the LPS-induced increase in prostaglandin E(2) plasma concentration, in contrast to ketoprofen. None of the three drugs were able to influence the elevation in body temperature after LPS administration. The pharmacokinetic properties of Na-salicylate and ketoprofen were not altered in combination with LPS administration. However, LPS significantly decreased the AUC(0→6 h) of the active metabolite of tepoxalin, RWJ-20142, indicating a perfusion-limited elimination for this molecule.

Report this publication

Statistics

Seen <100 times